Esomeprazole Magnesium Capsule, Delayed Release
Product Images NDC 50090-7360

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Esomeprazole Magnesium (NDC 50090-7360). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by A-s Medication Solutions, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Esomeprazolemagnesiumfigure1 (Esomeprazolemagnesiumfigure1)

FDA Label Image

Figure-2 (Figure 2)

Figure-2 (Figure 2)
Percent Maintained This text appears to list different products or treatments along with the number of subjects for each. It includes Esomeprazole Magnesium Delayed-Release Capsules in 40 mg, 20 mg, and 10 mg dosages, as well as a placebo group. The information may be related to a study or clinical trial evaluating the percentage of maintenance achieved by each treatment option.*
FDA Label Image

Figure-3 (Figure 3)

Figure-3 (Figure 3)
This text provides information about the percentage maintained throughout the study for different doses of Esomeprazole Magnesium Delayed-Release Capsules (10 mg, 20 mg, and 40 mg) compared to a placebo. The study includes a total number of participants for each dosage group and the placebo group (N=82, N=77) over a specific time period which is labeled as "Month."*
FDA Label Image

Figure-4 (Figure 4)

FDA Label Image

Figure-5 (Figure 5)

FDA Label Image

Label Image (Lbl500907360)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.